August 18, 2017

August 17, 2017

Subscribe to Latest Legal News and Analysis

August 16, 2017

Subscribe to Latest Legal News and Analysis

August 15, 2017

Subscribe to Latest Legal News and Analysis

What’s Next for Graduate Medical Education Accreditation? One System

Graduate medical education programs and residents should be getting used to change by now. Last year, the ACGME introduced the Next Accreditation System, and then eight months later, it announced it was developing a unified accreditation system with the American Osteopathic Association (AOA) and the American Association of Colleges of Osteopathic Medicine (AACOM), and that AOA and AACOM would become part of ACGME. The “merger” and subsequent unified accreditation system for graduate medical education programs could happen as early as July 2015.

Having one unified system is a mixed blessing for those affected by the change. On the one hand, both allopathic and osteopathic physicians will prepare for practice in the same way and be evaluated in the same way. On the other hand, it has raised questions among osteopathic physicians regarding how a unified accreditation system will affect osteopathic training, which is based on treating the whole patient, rather than treating just one part of the patient when eradicating disease. A unified system may be beneficial to hospitals’ Medicare GME reimbursements for training residents, but may be problematic for residents who find themselves “displaced” because of the Medicare GME funding cap or because their program has closed.

An article by Mintz Levin’s Nili Yolin, “The Future of GME Accreditation,” published by the American Health Lawyers Association, provides in-depth analysis of the unified accreditation system and how it may affect teaching hospitals, academic medical centers, and allopathic and osteopathic residency programs.

©1994-2017 Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. All Rights Reserved.


About this Author

Theresa Carnagie, Health Law Attorney, MIntz Levin Law Firm

Theresa’s practice involves a variety of transactional, regulatory, and fraud and abuse matters.

Her transactional experience focuses on advising health care clients on joint ventures, mergers and acquisitions, service agreements, and corporate stock and asset acquisitions. She has served as corporate and regulatory counsel to retail pharmacy chains, pharmacy benefit managers, and health care providers in acquisitions, which included due diligence, licensing, change of ownership, Medicare and Medicaid state certification, and contracting. She has deep experience preparing and...